文献
J-GLOBAL ID:201802263548256520
整理番号:18A1609203
プログラム死リガンド1の発現は骨髄肉腫患者における予後不良と関連する【JST・京大機械翻訳】
Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients
著者 (11件):
Kawamoto Keisuke
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
,
Kawamoto Keisuke
(Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan)
,
Miyoshi Hiroaki
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
,
Suzuki Takaharu
(Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan)
,
Kiyasu Junichi
(Department of Hematology, Iizuka Hospital, Iizuka, Japan)
,
Yokoyama Shintaro
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
,
Sasaki Yuya
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
,
Sone Hirohito
(Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan)
,
Seto Masao
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
,
Takizawa Jun
(Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan)
,
Ohshima Koichi
(Department of Pathology, Kurume University School of Medicine, Kurume, Japan)
資料名:
Hematological Oncology
(Hematological Oncology)
巻:
36
号:
3
ページ:
591-599
発行年:
2018年
JST資料番号:
D0357E
ISSN:
0278-0232
CODEN:
HAONDL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)